Showing 1 - 10 of 5,063
High prices and insufficient quality of care are observed in nursing homes in France. Reforms are currently under discussion, but governments are facing a dilemma : any measure of price cut is likely to affect quality and any improvement in quality would probably be inflationary. This work...
Persistent link: https://www.econbiz.de/10011074680
This primer aims to provide IMF macroeconomists with the essential information they need to address issues concerning health sector policy, particularly when they have significant macroeconomic implications. Such issues can also affect equity and growth and are fundamental to any strategy of...
Persistent link: https://www.econbiz.de/10012777849
The questions addressed in this paper are related to access rules to primary care services and the potential for patient driven competition between GPs and specialists. Most of the literature on the performance of primary care has dealt with reforming payment schemes, little attention being paid...
Persistent link: https://www.econbiz.de/10014071531
Poor medication practices and inadequate system infrastructure—resulting in poor adherence, medication-related harms, and medication errors—too often results in patient harm. As many as 1 in 10 hospitalizations in OECD countries may be caused by a medication-related event and as many one in...
Persistent link: https://www.econbiz.de/10013457960
Durch ungeeignete Arzneimitteltherapien und inadäquate Systeminfrastrukturen, die unzureichende Adhärenz, medikationsbedingte Schäden und Medikationsfehler nach sich ziehen, kommen nur allzu oft Patient*innen zu Schaden. Im OECD-Raum ist möglicherweise ein Zehntel der Krankenhauseinweisungen...
Persistent link: https://www.econbiz.de/10014436006
BACKGROUND: In 2005, the French Government implemented a new way of financing high-cost drugs for hospitals in order to … price cap. Hospitals still negotiate with pharmaceutical firms, who set their prices freely, and then charge the national … in negotiation from hospitals, as supplementary funding could reduce hospital price sensitivity. OBJECTIVES: The aim of …
Persistent link: https://www.econbiz.de/10010706947
Background: Economic evaluation (EE) is a dynamically advancing knowledge area of health economics. It has been conceived to provide evidence for allocating scarce resources to gain the best value for money. The problem of efficiency of investments becomes even more crucial with advances in...
Persistent link: https://www.econbiz.de/10011890361
Medical cost-effectiveness analysis (CEA) is perhaps the most widely applied tool to guide policy decisions concerning the use of health care resources. This chapter first reviews the rationale for and common practice of medical cost-effectiveness analysis. It seeks to place CEA within a...
Persistent link: https://www.econbiz.de/10014025581
There are 3 demand sources in healthcare systems: the patient, provider and payor. Patient-determined demand is characterised as `random access' and emotionally charged. Provider-determined demand occurs within working environments that do not inherently support integration activities....
Persistent link: https://www.econbiz.de/10005448834
Equity in health has to be distinguished from equity in access to health care, or equity in the distribution of health care resources. We take as a working definition of health for our purposes the number of quality adjusted life years that a person may expect to enjoy over his or her lifetime....
Persistent link: https://www.econbiz.de/10014024170